Insurer-mandated medication utilization barriers are associated with decreased insurance satisfaction and adverse clinical outcomes: an ibd partners survey

Insurer-mandated barriers to timely initiation of advanced therapies used to treat inflammatory bowel disease (IBD) have been shown to worsen clinical outcomes and increase healthcare utilization, yet rarely alter the medication ultimately prescribed. Using the IBD Partners research network, we analyzed patient-reported impacts of these barriers on insurance satisfaction and clinical outcomes.
Source: Gastroenterology - Category: Gastroenterology Authors: Source Type: research